Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,704 public trials 1,044 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

M7824 Versus Pembrolizumab as a First-line (1L) Treatment in Participants With Programmed Death-ligand 1 (PD-L1) Expressing Advanced Non-small Cell Lung Cancer (NSCLC)

NCT03631706

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Oncology Specialties, PC; Clearview Cancer Institute Huntsville, Alabama, United States
  • Cedars Sinai Medical Center - Inflammatory Bowel Disease Center (Clinic Los Angeles, California, United States
  • UC Irvine Medical Center Orange, California, United States
  • Kaiser Permanente - Harbor City San Diego, California, United States
View all 119 locations
View Trial Details
Completed

AB-16B5 Combined With Docetaxel in Subjects With Metastatic Non-Small Cell Lung Cancer (EGIA-002)

NCT04364620

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Hôpital Maisonneuve-Rosemont Montreal, Quebec, Canada
  • Centre Hospitalier de l'Université de Montréal (CHUM) Montreal, Quebec, Canada
  • Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ) Québec, Quebec, Canada
View Trial Details
Completed

Study of XB002 in Subjects With Solid Tumors (JEWEL-101)

NCT04925284

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +57 more
Locations
  • Exelixis Clinical Site #48 Birmingham, Alabama, United States
  • Exelixis Clinical Site #20 Tucson, Arizona, United States
  • Exelixis Clinical Site#95 Tucson, Arizona, United States
  • Exelixis Clinical Site#58 Little Rock, Arkansas, United States
View all 95 locations
View Trial Details
Completed

Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Nonsmall Cell Lung Cancer (NSCLC) [MK-7902-007/E7080-G000-314/LEAP-007] - China Extension Study

NCT04676412

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Anhui Provincial Hospital ( Site 0108) Hefei, Anhui, China
  • The First Affiliated Hospital of Anhui Medical University ( Site 0113) Hefei, Anhui, China
  • Peking Union Medical College Hospital ( Site 0105) Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital ( Site 0102) Beijing, Beijing Municipality, China
View all 17 locations
View Trial Details
Completed

Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)

NCT04330664

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +28 more
Locations
  • Local Institution - 002-805 Los Angeles, California, United States
  • Local Institution - 002-803 Orange, California, United States
  • Local Institution - 002-828 Chicago, Illinois, United States
  • Local Institution - 002-942 Wichita, Kansas, United States
View all 17 locations
View Trial Details
Completed

SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas

NCT03894618

Conditions
Adenocarcinoma, Anus Diseases, Anus Neoplasms, +68 more
Locations
  • The Sarah Cannon Research Institute Nashville, Tennessee, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Leuven Cancer Institute Leuven, Belgium
  • Princess Margaret Cancer Center Toronto, Ontario, Canada
View Trial Details

Related conditions